Pharmaceuticals

This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.

06 May 2016  |  Asia Pacific

Global Generic Pharmaceuticals Market, Forecast to 2020

Market Participants Target High Value-added Branded Generics and Biosimilars Segments

Infographics

×

The key objectives of this research service are to gain an in-depth knowledge of the major markets and therapeutic areas and organizations presenting significant growth opportunities for generics, to understand the impact of regulation on the market, and to outline the industry consolidation trends that will continue shaping the future of generics....

The high prevalence of diseases in Europe is a market opportunities for the market participants, especially considering the ageing population in these regions. This leads to the need for better and early diagnosis. This market includes revenues from instruments and reagents. Market revenues and installed base (units) for the entire Western Europe, ...

This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in biosimilars, cancer screening, molecular scissors, next generation stem cells, three-dimensional (3D) scaffolds, therapeutic antibodies, cancer immunotherapy, high throug...

Medical imaging modalities such as X-ray imaging, magnetic resonance imaging, positron emission tomography, and others, have been designed to capture high resolution images through minimally-invasive approaches. However, each of these also suffer from limitations, foremost of which is that they utilize ionizing radiation that is hazardous to the pa...

The growing population base, driven by increased life expectancy and domestic investment, is expected to continuously accelerate GDP in Malaysia. Significant growth of healthcare expenditure is expected in the country to facilitate the improvement of medical access and provide companies with revenue-earning opportunities from 2015. Positive macroec...

This market insight provides an analysis of the regulatory trends occurring in the US life sciences market. Included in this deliverable is an analysis of the new molecular entities (NMEs) approved by the US Food and Drug Administration and predictions for 2014. Trends are showing that the Food and Drug Administration is moving towards greater ef...